-
Mashup Score: 1With medical devices market expected to soar, here are companies set to benefit the most - 2 year(s) ago
The global medical devices market was ~$489B, and is projected to increase to ~$496B in 2022.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1With medical devices market expected to soar, here are companies set to benefit the most - 2 year(s) ago
The global medical devices market was ~$489B, and is projected to increase to ~$496B in 2022.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @dandrnbrgr: With medical devices market expected to soar, here are companies set to benefit the most https://t.co/G78yYqiod2
-
-
Mashup Score: 1Twitter delisting from NYSE effective on Friday after Musk completes deal (NYSE:TWTR) - 2 year(s) ago
Twitter (TWTR) is set to be delisted from the New York Stock Exchange effective on Friday, according a delisting notice from the exchange. The delisting notice comes amid a WSJ report…
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
Twitter delisting from NYSE effective on Friday after Musk completes deal https://t.co/9jbWBrhx0o
-
-
Mashup Score: 0Arm loses 40% of UK staff despite SoftBank pledge to grow domestic workforce: report - 2 year(s) ago
Arm, the chip design firm owned by SoftBank (SFTBY), has seen more than 40% of its U.K. workforce that it gained in recent years leave the company, the Financial Times reported.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Arm loses 40% of UK staff despite #SoftBank pledge to grow domestic workforce https://t.co/yS5rnkmzp4
-
-
Mashup Score: 2
The shares of MedTech firm Lucira Health, Inc. (LHDX) spiked pre-market Wednesday after the company announced interim data from a pilot study designed to evaluate its combined Chlamydia…
Source: SeekingAlphaCategories: Infectious Disease, Latest HeadlinesTweet-
““….our POCT is a game changer for improving clinical practice to prevent and control both Chlamydia trachomatis and Neisseria gonorrhoeae sexually transmitted infections (STIs) in diverse health care settings globally,” https://t.co/XRGbOvxcZB
-
-
Mashup Score: 0Twitter likely to win in court, First Horizon/TD bank likely to be approved (NYSE:TWTR) - 2 year(s) ago
Twitter (TWTR) is likely to win its court battle with billionaire Elon Musk over his attempts to get out of his $44 billionaire takeover of the social media company
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
Twitter likely to win in court, First Horizon/TD Bank likely to be approved - investor https://t.co/5jTSBoTmO6
-
-
Mashup Score: 1
The market for application software is at risk of a recession hitting the tech sector, but there remain core opportunities for companies in areas where corporate spending is seen…
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
Application software companies seen with opportunities among a challenging economy https://t.co/Zz26NTk7kT
-
-
Mashup Score: 4
Intuitive faces serious headwinds with its end markets being severely impacted. See why I think there is more pain ahead for ISRG stock.
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@IntuitiveSurg: Raising Red Flag On Hospital Industry | #roboticsurgery #opex #hospitals #medicaldevices | NASDAQ: $ISRG https://t.co/BFlU0FbUCV
-
-
Mashup Score: 0Novartis ALS therapy sotuletinib gets FDA orphan drug status - 2 year(s) ago
The U.S. Food and Drug Administration ((FDA)) granted orphan drug designation to Novartis’ (NVS) sotuletinib to treat patients with Amyotrophic Lateral Sclerosis ((ALS)).ALS is…
Source: SeekingAlphaCategories: Latest Headlines, Rare DiseaseTweet-
$NVS sotuletinib https://t.co/uC5cBn1tdR
-
-
Mashup Score: 1
23andMe (ME) stock fell ~14% premarket Aug. 9 after the company’s Q1 net loss widened Y/Y due to higher operating expenses.Q1 FY23 total revenue grew ~9% Y/Y to $64.51M
Source: SeekingAlphaCategories: Healthcare Professionals, Latest HeadlinesTweet-
$ME - 23andMe stock slumps 14% as Q1 net loss widens on higher operating expenses https://t.co/H2nHyuLkcr #telemedicine #telehealth #technology #healthcare #artificialintelligence #digitalhealth #behavioralhealth #mentalhealth #connectedhealth
-
RT @medtechanswers: With medical devices market expected to soar, here are companies set to benefit the most https://t.co/m9K77sWMEM